(2018)
The secreted Candida albicans protein Pra1 disrupts host defense by broadly targeting and blocking complement C3 and C3 activation fragments.
Mol Immunol 93,
266-277.
Publikationen
(2018)
Streptococcus pneumoniae from patients with hemolytic uremic syndrome binds human plasminogen via the surface protein PspC and uses plasmin to damage human endothelial cells.
J Infect Dis 217(3),
358-370.
(2018)
The MFHR1 fusion protein is a novel synthetic multitarget complement inhibitor with therapeutic potential.
J Am Soc Nephrol 29(4),
1141-1153.
(2018)
Evaluation of serum sphingolipids and the influence of genetic risk factors in age-related macular degeneration.
PLOS One 13(8),
e0200739.
(2018)
FHR-1 binding impairs factor H-mediated complement evasion by the malaria parasite Plasmodium falciparum.
J Immunol 201(12),
3497-3502.
(2018)
FHR5 binds to laminins, uses separate C3b and surface-binding sites, and activates complement on malondialdehyde-acetaldehyde surfaces.
J Immunol 200(7),
2280-2290.
(2018)
Membranoproliferative glomerulonephritis and C3 glomerulopathy in children: Change in treatment modality? A report on a case series.
Clin Kidney J 11(4),
479-490.
(2018)
Reply to kang and brooks: Comment on the interpretation of binding of Pra1, the fungal immune evasion protein from Candida albicans to the human C3 and on the conformational changes of C3 upon activation: Kang and brooks optimization of biolayer-interfero.
Mol Immunol 101,
638-639.
(2017)
A tale of four kingdoms - isoxazolin-5-one- and 3-nitropropanoic acid-derived natural products.
Natural Product Reports 34(4),
343-360.
(2017)
Direct Binding of the pH-Regulated Protein 1 (Pra1) from Candida albicans Inhibits Cytokine Secretion by Mouse CD4(+) T Cells.
Front Microbiol 8,
844.